T1	Participants 64 157	spinal anesthesia after prophylactic administration of intravenous fluids or vasoconstrictors
T2	Participants 402 470	Patients (n = 1066) were randomly allocated to either a volume group
T3	Participants 549 574	a dihydroergotamine group
T4	Participants 624 639	a placebo group
T5	Participants 268 285	spinal anesthesia
T6	Participants 1608 1625	spinal anesthesia
T7	Participants 1401 1418	spinal anesthesia
